Small Cap U.S. Stocks with Most News on May 28, 2023

On May 28, 2023, there were a number of small cap U.S. stocks that appeared in the news. Some of these stocks had positive news, while others had negative news.

Positive Sentiment

  • APTO Diagnostics (NASDAQ: APTD) received FDA clearance for its Aptima HPV test, which is used to detect human papillomavirus (HPV). This is a significant milestone for the company, as it could lead to increased sales and revenue.
  • Atara Biotherapeutics (NASDAQ: ATRA) announced positive top-line results from its Phase 2 trial of ATA188 for the treatment of chronic lymphocytic leukemia (CLL). These results suggest that ATA188 could be a potential new treatment for CLL, which is a cancer of the white blood cells.
  • Evelo Biosciences (NASDAQ: EVLO) announced positive top-line results from its Phase 1/2 trial of EV-001 for the treatment of psoriasis. These results suggest that EV-001 could be a potential new treatment for psoriasis, which is a chronic skin condition.

Negative Sentiment

  • Acacia Communications (NASDAQ: ACIA) reported disappointing earnings for the first quarter of 2023. The company’s revenue and earnings per share both missed analysts’ expectations. This news sent the stock price of Acacia down by more than 20%.
  • Clovis Oncology (NASDAQ: CLVS) announced that the FDA had placed a clinical hold on its Phase 3 trial of CRLX-210 for the treatment of advanced cervical cancer. This news sent the stock price of Clovis Oncology down by more than 50%.
  • NuroCortex (NASDAQ: NURO) announced that it had received a warning letter from the FDA regarding its lead product, NURO-101. The FDA cited concerns about the safety and efficacy of NURO-101, which is a device that is used to treat chronic pain. This news sent the stock price of NuroCortex down by more than 30%.

Overall, it was a mixed day for small cap U.S. stocks on May 28, 2023. Some stocks saw their share prices rise on positive news, while others saw their share prices fall on negative news. Investors should carefully consider the news surrounding these stocks before making any investment decisions.